LONDON, Sept. 27, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Ralph Hughes as Vice President to lead its Pricing and Market Access practice.
LONDON, March 24, 2022 /PRNewswire/ -- PharmaVentures is pleased to announce that it acted as transaction advisor to Lausanne University Hospital (CHUV) and EPFL in Switzerland on their commercial terms related to the collaboration and licensing of their highly potent SARS-CoV-2 monoclonal antibodies to the newly founded biopharmaceutical company Aerium Therapeutics, based in Boston, MA, USA and Lausanne, Switzerland.